Compositions for topical administration of a hedgehog inhibitor compound are described. In one embodiment, the hedgehog inhibitor compound is patidegib and the topical composition comprises the compound in a solvent system of a monohydric primary alcohol and a polyol in a w/w ratio of between about 0.9-1.8. In another embodiment, the hedgehog inhibitor is itraconazole and the topical composition comprises the compound in a solvent system comprising a monohydric primary alcohol and an optionally lower alkyl end-capped oligomeric alkylene glycol in a w/w ratio of between about 0.8 and 2.6 and a fused bicyclic ether. Method of using the compositions are also described, where in one embodiment, the compositions are topically applied for treating or preventing basal cell carcinoma.
本文描述了用于局部施用刺猬
抑制剂化合物的组合物。在一个实施方案中,刺猬
抑制剂化合物是帕替吉布,外用组合物包括在一元醇和多元醇的溶剂体系中的化合物,两者的重量比约为 0.9-1.8 之间。在另一个实施方案中,刺猬
抑制剂是
伊曲康唑,外用组合物包括该化合物在溶剂体系中,该溶剂体系包括一元醇和任选低级烷基末端封端的低聚亚烷基二醇,其重量/重量比在约 0.8 至 2.6 之间,以及熔融双
环醚。还描述了组合物的使用方法,在一个实施方案中,组合物局部应用于治疗或预防基底细胞癌。